Clostridium perfringens—Opportunistic Foodborne Pathogen, Its Diversity and Epidemiological Significance Original paper

What was reviewed?

This review examined the microbiology, toxin production, epidemiology, molecular diversity, and public health significance of Clostridium perfringens, an anaerobic opportunistic pathogen that exists both as a normal component of the gastrointestinal microbiota and as a cause of systemic and enteric disease. The authors synthesized evidence regarding toxinotypes, genetic diversity, antimicrobial resistance, environmental persistence, and host interactions across human and animal populations. The review emphasized how toxin genes, plasmid-mediated virulence, and microbial adaptability enable C. perfringens to transition from a commensal organism in the gut microbiome to a pathogenic species capable of foodborne illness, enterocolitis, and systemic infections.

Who was reviewed?

The review analyzed findings from multiple microbiological, genomic, epidemiological, and experimental studies involving Clostridium perfringens isolates from humans, livestock, poultry, and environmental sources such as food, soil, and sewage. These included studies examining toxin gene prevalence, genomic sequencing, toxinotype classification (A–G), antimicrobial resistance patterns, and disease associations across diverse hosts. The review also incorporated research investigating microbiome-related colonization patterns, particularly in gastrointestinal environments of healthy individuals, hospitalized patients, and animal hosts susceptible to enteric infections.

What were the most important findings?

The review demonstrated that Clostridium perfringens is a core but opportunistic member of the gastrointestinal microbiome whose pathogenicity depends primarily on toxin production, genomic diversity, and environmental triggers that allow expansion of virulent strains. Major microbial associations include toxin-producing strains, particularly toxinotype F strains that produce enterotoxin (CPE), which disrupt intestinal epithelial barrier integrity by binding claudin receptors and forming pores that trigger calcium influx, inflammation, epithelial cell death, and diarrhea. The organism produces more than 20 toxins, including α-toxin, enterotoxin, perfringolysin O, and NetB toxin, which impair immune responses, damage host tissue, and promote disease progression.

Genomic analysis revealed that C. perfringens has an unusually diverse pangenome of over 11,000 genes, with extensive horizontal gene transfer and plasmid-encoded toxin genes that facilitate rapid adaptation and virulence acquisition. The organism forms heat-resistant spores capable of surviving cooking and environmental stress, allowing recolonization of the gut microbiome after disruption such as antibiotic exposure. The review also found increasing antimicrobial resistance among isolates, particularly resistance associated with antimicrobial use in livestock and healthcare environments, which enhances persistence and pathogenic potential. Importantly, the review emphasized that detection of toxin genes, rather than simple presence of the organism, is essential for diagnosing disease because non-toxigenic strains commonly exist as harmless commensals in the microbiome.

What are the greatest implications of this review?

This review establishes Clostridium perfringens as a critical microbiome-associated opportunistic pathogen whose pathogenicity depends on toxin gene expression, plasmid-mediated virulence, and microbiome disruption. Clinicians should recognize that the mere presence of C. perfringens in the microbiome does not indicate disease; rather, toxin-producing strains and dysbiosis drive pathology. The organism’s extensive genomic diversity, antimicrobial resistance, and ability to persist as spores make it highly adaptable and difficult to control. These findings emphasize the importance of microbiome stability, antimicrobial stewardship, and toxin gene testing in diagnosing and managing gastrointestinal infections. Furthermore, microbiome-targeted interventions, including probiotics, microbiota restoration therapies, vaccines, and phage therapy, may provide future therapeutic strategies to prevent opportunistic expansion and toxin-mediated disease caused by C. perfringens.